12/31
07:35 pm
crsp
CRISPR Therapeutics AG (CRSP) Increases Despite Market Slip: Here's What You Need to Know [Yahoo! Finance]
Medium
Report
CRISPR Therapeutics AG (CRSP) Increases Despite Market Slip: Here's What You Need to Know [Yahoo! Finance]
12/30
11:34 pm
crsp
CRISPR Therapeutics AG (NASDAQ: CRSP) was upgraded by analysts at StockNews.com to a "sell" rating.
Low
Report
CRISPR Therapeutics AG (NASDAQ: CRSP) was upgraded by analysts at StockNews.com to a "sell" rating.
12/26
07:14 pm
crsp
CRISPR Therapeutics AG (CRSP) Advances While Market Declines: Some Information for Investors [Yahoo! Finance]
Low
Report
CRISPR Therapeutics AG (CRSP) Advances While Market Declines: Some Information for Investors [Yahoo! Finance]
12/22
12:37 pm
crsp
This Beaten-Down Biotech Stock Just Got Some Good News: Time to Buy? [Yahoo! Finance]
Low
Report
This Beaten-Down Biotech Stock Just Got Some Good News: Time to Buy? [Yahoo! Finance]
12/22
04:42 am
crsp
Should You Buy Vertex Pharmaceuticals on the Dip Before Potentially Enormous News in January 2025? [Yahoo! Finance]
Low
Report
Should You Buy Vertex Pharmaceuticals on the Dip Before Potentially Enormous News in January 2025? [Yahoo! Finance]
12/20
09:44 am
crsp
1 big new Green Flag for CRISPR Therapeutics' Stock [Yahoo! Finance]
Low
Report
1 big new Green Flag for CRISPR Therapeutics' Stock [Yahoo! Finance]
12/20
08:55 am
crsp
CRISPR Therapeutics AG (NASDAQ: CRSP) had its "market outperform" rating re-affirmed by analysts at JMP Securities. They now have a $86.00 price target on the stock.
Low
Report
CRISPR Therapeutics AG (NASDAQ: CRSP) had its "market outperform" rating re-affirmed by analysts at JMP Securities. They now have a $86.00 price target on the stock.
12/19
07:49 am
crsp
Capsida Biotherapeutics to Present at 43rd Annual J.P. Morgan Healthcare Conference [Yahoo! Finance]
Low
Report
Capsida Biotherapeutics to Present at 43rd Annual J.P. Morgan Healthcare Conference [Yahoo! Finance]
12/18
09:01 am
crsp
Celebrating a Milestone: Engineering Tomorrow Reaches 1 Million Students [Yahoo! Finance]
Medium
Report
Celebrating a Milestone: Engineering Tomorrow Reaches 1 Million Students [Yahoo! Finance]
12/17
05:42 am
crsp
2 Growth Stocks That Could Rocket Higher in 2025: Are They Right for Your Portfolio? [Yahoo! Finance]
Low
Report
2 Growth Stocks That Could Rocket Higher in 2025: Are They Right for Your Portfolio? [Yahoo! Finance]
12/16
12:27 pm
crsp
EDIT Stock Falls on Decision to End Reni-Cel Studies, Cut Workforce [Yahoo! Finance]
Low
Report
EDIT Stock Falls on Decision to End Reni-Cel Studies, Cut Workforce [Yahoo! Finance]
12/14
09:58 am
crsp
3 Things You Need to Know if You Buy CRISPR Therapeutics Today [Yahoo! Finance]
Low
Report
3 Things You Need to Know if You Buy CRISPR Therapeutics Today [Yahoo! Finance]
12/11
11:03 pm
crsp
CRISPR Therapeutics AG (NASDAQ: CRSP) was upgraded by analysts at StockNews.com to a "sell" rating.
Medium
Report
CRISPR Therapeutics AG (NASDAQ: CRSP) was upgraded by analysts at StockNews.com to a "sell" rating.
12/10
08:00 am
crsp
CRISPR Therapeutics AG (NASDAQ: CRSP) had its "buy" rating re-affirmed by analysts at Chardan Capital. They now have a $94.00 price target on the stock.
Medium
Report
CRISPR Therapeutics AG (NASDAQ: CRSP) had its "buy" rating re-affirmed by analysts at Chardan Capital. They now have a $94.00 price target on the stock.
12/9
12:07 pm
crsp
CRISPR Therapeutics Presents Data at the 2024 American Society of Hematology (ASH) Annual Meeting [Yahoo! Finance]
Low
Report
CRISPR Therapeutics Presents Data at the 2024 American Society of Hematology (ASH) Annual Meeting [Yahoo! Finance]
12/9
12:00 pm
crsp
CRISPR Therapeutics Presents Data at the 2024 American Society of Hematology (ASH) Annual Meeting
Low
Report
CRISPR Therapeutics Presents Data at the 2024 American Society of Hematology (ASH) Annual Meeting
12/7
08:57 am
crsp
2 Biotech Stocks to Buy Hand Over Fist in December [Yahoo! Finance]
Medium
Report
2 Biotech Stocks to Buy Hand Over Fist in December [Yahoo! Finance]
12/6
02:04 pm
crsp
CRISPR Therapeutics (CRSP) Upgraded to Buy: What Does It Mean for the Stock? [Yahoo! Finance]
Low
Report
CRISPR Therapeutics (CRSP) Upgraded to Buy: What Does It Mean for the Stock? [Yahoo! Finance]
12/5
05:43 am
crsp
3 of the Best Growth Stocks You Can Buy for Less than $100 [Yahoo! Finance]
Medium
Report
3 of the Best Growth Stocks You Can Buy for Less than $100 [Yahoo! Finance]
12/4
06:40 pm
crsp
Tomorrow's Promise, Today's Roswell Park: Leaders Tackling the Biggest Priorities in Cancer Care and Treatment
Medium
Report
Tomorrow's Promise, Today's Roswell Park: Leaders Tackling the Biggest Priorities in Cancer Care and Treatment
12/4
08:22 am
crsp
Cellino Appoints Chris Gemmiti, Ph.D., as SVP of Therapeutics Development [Yahoo! Finance]
Low
Report
Cellino Appoints Chris Gemmiti, Ph.D., as SVP of Therapeutics Development [Yahoo! Finance]
11/25
08:02 am
crsp
Capsida Biotherapeutics to Present at 7th Annual Evercore HealthCONx Conference [Yahoo! Finance]
Low
Report
Capsida Biotherapeutics to Present at 7th Annual Evercore HealthCONx Conference [Yahoo! Finance]
11/24
05:52 am
crsp
Down 47% Since March, Is CRISPR Therapeutics Stock a Buy on the Dip? [Yahoo! Finance]
Medium
Report
Down 47% Since March, Is CRISPR Therapeutics Stock a Buy on the Dip? [Yahoo! Finance]
11/23
06:40 am
crsp
3 Monster Stocks in the Making [Yahoo! Finance]
Medium
Report
3 Monster Stocks in the Making [Yahoo! Finance]
11/22
09:14 am
crsp
Genome Editing Market Size Projected to Reach USD 32.72 Billion by 2032, Driven by Advances in CRISPR and Gene Therapies – SNS Insider [Yahoo! Finance]
Low
Report
Genome Editing Market Size Projected to Reach USD 32.72 Billion by 2032, Driven by Advances in CRISPR and Gene Therapies – SNS Insider [Yahoo! Finance]